Inspiro Medical Ltd. is a medical device company dedicated to the development of a global inhalation platform designed to deliver both small molecules such as corticosteroids or beta agonists; and macromolecules such as antibodies or vaccines. The Company is currently performing clinical trials with asthmatic children using Inspiromatic™, its proprietary dry powder inhaler.
Inspiro Medical operates within the framework of the Misgav Venture Accelerator, and has received funding from The Trendlines Group, Israel’s foremost seed- and early-stage investment group.
Nimrod Kaufmann, CEO
Nimrod has more than 10 years of experience in the medical device industry, taking products from initial concept through manufacturing.
He holds a BSc in Mechanical Engineering from Ben Gurion University.
Dr. Guy Steuer, MD, Inventor
Dr. Steuer is a senior physician and pediatric pulmonologist at Schneider’s Children Medical Center; a frequent lecturer at Tel-Aviv University; and has been involved in the development of numerous medical devices. He has served as consultant to Tree of Life Pharma Ltd. and Stata Venture Partners, among others. Dr. Steuer holds a BSc and MD from The Hebrew University of Jerusalem, as well as a pulmonology fellowship from the University of Pittsburgh.